T. Rowe Price Investment Management, Inc. Rx Sight, Inc. Call Options Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RXST
# of Institutions
224Shares Held
32.3MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$150 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$91.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$87.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$66.7 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$44.7 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.06B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...